CYPH

0.90

5.26% -0.05

Vorhandelsmarkt: .89 -0.01 -1.11%

Cypherpunk Technologies Inc (CYPH)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

$0.95

Offen:

$0.94

24-Stunden-Volumen:

2.41M

Relative Volume:

0.96

Marktkapitalisierung:

$80.98M

Einnahmen:

Nettoeinkommen (Verlust:

$4.82M

KGV:

13.27

EPS:

0.0678

Netto-Cashflow:

$-140.90M

1W Leistung:

+11.48%

1M Leistung:

+55.17%

6M Leistung:

+0.00%

1J Leistung:

+0.00%

1-Tages-Spanne:

$0.871

$0.9694

1-Wochen-Bereich:

$0.75

$1.14

52-Wochen-Spanne:

$0.50

$3.6999

Cypherpunk Technologies Inc Stock (CYPH) Company Profile

Firmenname

Cypherpunk Technologies Inc

Sektor

Healthcare (1112)

Branche

Biotechnology (621)

Telefon

617 252 4343

Adresse

47 THORNDIKE STREET, CAMBRIDGE

Mitarbeiter

Twitter

Nächster Verdiensttermin

2026-03-25

Neueste SEC-Einreichungen

CYPH's Discussions on Twitter

Compare CYPH vs VRTX, REGN, ARGX, ALNY, ONC

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CYPH Cypherpunk Technologies Inc	0.90	80.98M	0	4.82M	-140.90M	0.0678
VRTX Vertex Pharmaceuticals Inc	441.70	112.35B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	753.93	79.71B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	840.87	52.29B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	333.39	44.48B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	319.94	35.51B	5.36B	287.73M	924.18M	2.5229

Cypherpunk Technologies Inc Stock (CYPH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-01-29	Herabstufung	H.C. Wainwright	Buy → Neutral
2025-01-29	Herabstufung	Robert W. Baird	Outperform → Neutral
2024-06-28	Eingeleitet	Rodman & Renshaw	Buy
2021-10-04	Eingeleitet	Mizuho	Buy
2021-06-04	Fortgesetzt	Robert W. Baird	Outperform
2020-06-29	Eingeleitet	Piper Sandler	Overweight
2020-02-11	Eingeleitet	Robert W. Baird	Outperform
2019-11-15	Herabstufung	Raymond James	Outperform → Mkt Perform
2019-09-13	Fortgesetzt	Raymond James	Outperform
2017-03-07	Eingeleitet	Ladenburg Thalmann	Buy

Alle ansehen

Cypherpunk Technologies Inc Aktie (CYPH) Neueste Nachrichten

Apr 15, 2026

Top Cypherpunk Technologies (CYPH) Competitors 2026 - MarketBeat

Apr 15, 2026

Cypherpunk Technologies Expands ZEC Holdings with New Purchase - GuruFocus

Apr 15, 2026

Cypherpunk Technologies Acquires New ZEC and Launches New Website - Intellectia AI

Apr 15, 2026

Cypherpunk Increases its Zcash Stake, Launches New Website and Investor Dashboard - PR Newswire

Apr 15, 2026

Apr 11, 2026

Cypherpunk Technologies Inc. Files Form 8-K with SEC – Company Details, Stock Symbol, and NASDAQ Listing Information - Minichart

Apr 11, 2026

Apr 10, 2026

Cypherpunk Technologies announces retirement of four board members ahead of annual meeting By Investing.com - Investing.com Australia

Apr 10, 2026

Cypherpunk Technologies announces retirement of four board members ahead of annual meeting - Investing.com Australia

Apr 10, 2026

Cypherpunk's ZODL Investment: A Tactical Bet to Turn Around Zcash's Decline - Bitget

Apr 10, 2026

Cypherpunk Technologies Announces Planned Board Leadership Transitions - TipRanks

Apr 10, 2026

Four Cypherpunk (CYPH) directors set to retire at 2026 meeting - Stock Titan

Apr 10, 2026

Apr 09, 2026

9 Health Care Stocks Moving In Wednesday's Pre-Market Session - Sahm

Apr 09, 2026

Cypherpunk Technologies (NASDAQ:CYPH) Trading 10.7% HigherHere's What Happened - MarketBeat

Apr 09, 2026

Apr 04, 2026

Leap Therapeutics Stock More Than Doubles On Zcash Treasury Pivot – Former POTUS Advisor Calls It ‘Gangster’ Move - MSN

Mar 27, 2026

Mar 25, 2026

Cypherpunk Technologies restructures CoinXit equity compensation agreement - MSN

Mar 25, 2026

Mar 20, 2026

CYPH.O Technical Analysis & Stock Price Forecast - Intellectia AI

Mar 20, 2026

Mar 19, 2026

Cypherpunk Technologies Inc. - AD HOC NEWS

Mar 19, 2026

Mar 18, 2026

Cypherpunk Technologies (CYPH) Stock Forecast and Price Target 2026 - MarketBeat

Mar 18, 2026

Mar 17, 2026

Cypherpunk Technologies (CYPH) director converts 104,500 RSUs to 152,500 share stake - Stock Titan

Mar 17, 2026

Cypherpunk (CYPH) director converts 168,750 vested RSUs into common stock - Stock Titan

Mar 17, 2026

Director at Cypherpunk (CYPH) receives 168,750 shares from RSUs - Stock Titan

Mar 17, 2026

Director William Li of Cypherpunk (CYPH) receives 168,750 shares from RSU settlements - Stock Titan

Mar 17, 2026

RSU settlements give Cypherpunk (CYPH) director 168,750 common shares - Stock Titan

Mar 17, 2026

Cypherpunk Technologies (CYPH) director converts 168,750 RSUs into common shares - Stock Titan

Mar 17, 2026

Cypherpunk (CYPH) director converts 168,750 RSUs into common stock - Stock Titan

Mar 17, 2026

Director at Cypherpunk (CYPH) gains 168,750 shares via RSU settlements - Stock Titan

Mar 17, 2026

Director Loscalzo acquires 168,750 Cypherpunk (CYPH) shares via RSUs - Stock Titan

Mar 17, 2026

Director Cavanaugh acquires 168,750 Cypherpunk (CYPH) shares from RSUs - Stock Titan

Mar 17, 2026

ZEC Rallies 20% After Cypherpunk Reports First Annual Profit - thedefiant.io

Mar 17, 2026

CYPH.O PE Ratio & Valuation, Is CYPH.O Overvalued - Intellectia AI

Mar 17, 2026

CYPH.O Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Mar 17, 2026

CYPH.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Mar 17, 2026

CYPH Should I Buy - Intellectia AI

Mar 17, 2026

CYPH.O Forecast — Price Prediction for 2026. Should I Buy CYPH.O? - Intellectia AI

Mar 17, 2026

Cypherpunk Technologies Inc. (Formerly Leap Therapeutics) Combines Digital Privacy Tech and Cancer Drug Development – 2025 Annual Report Overview - Minichart

Mar 17, 2026

Security Notice: Cysic Foundation X Account Breached - Bitget

Mar 17, 2026

Mar 16, 2026

Cypherpunk reports full year 2025 financial results - marketscreener.com

Mar 16, 2026

Cypherpunk Reports Full Year 2025 Financial Results - National Today

Mar 16, 2026

Cypherpunk Technologies Reports Transformational 2025 Financial Results - Intellectia AI

Mar 16, 2026

Cypherpunk Technologies 10-K: Revenue $0, EPS $0.07 on $4.8M Net Income - TradingView

Mar 16, 2026

CYPH: 2025 saw a strategic pivot to Zcash, a return to profitability, and major digital asset gains - TradingView

Mar 16, 2026

Cypherpunk Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 16, 2026

Cypherpunk Technologies (CYPH) pivots to Zcash while advancing cancer drugs - Stock Titan

Mar 16, 2026

CYPH: Returned to profitability in 2025 with strong ZEC gains, new capital, and clinical progress - TradingView

Mar 16, 2026

[8-K] CYPHERPUNK TECHNOLOGIES INC. Reports Material Event | CYPH SEC FilingForm 8-K - Stock Titan

Mar 16, 2026

Mar 13, 2026